Publications by authors named "T Decroo"

Claim this Profile
T
The time is now: making the case for compassionate use/pre-approval access to new TB drugs.
A Reuter, J Stillo, S S Thi, I Motta, G B Migliori, T DeCroo

IJTLD Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative study on pre-exposure prophylaxis uptake and retention among men who have sex with men and transgender women in Myanmar.
Ni Ni Tun, Soe Yu Naing, Nyan Lynn Tun, Myo Min Min Hteik, Myat Ko Ko, Tom Decroo

Int Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From trials to programmatic scale-up: treatment outcomes of rifampicin-resistant tuberculosis during transition to short oral regimens in Vietnam (2021-2022).
Thi Mai Phuong Nguyen, Van Luong Dinh, Binh Hoa Nguyen, Thi Thanh Thuy Hoang, Viet Nhung Nguyen, Tom Decroo

Int J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.
J Snobre, J Gasana, T Decroo, Y Mucyo, B K M Jacobs

IJTLD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High loss to follow-up on a bedaquiline-based regimen for rifampicin-resistant TB.
F Idowu, T Decroo, A Mesic

IJTLD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis